newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Regains Compliance with Nadaq Minimum Bid Price Requirement

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it has received notification from the Nasdaq Stock Market informing the Company that as of June 20, 2023 it has regained compliance with the minimum bid price